AlphaCrest Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

AlphaCrest Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,933	Closed	-$202K	–	1219
2022 Q3	$202K	Buy	+10,933	New	+$172K	0.01%	1235
2021 Q3	–	Sell	-44,600	Closed	-$1.63M	–	1415
2021 Q2	$1.63M	Buy	+44,600	New	+$1.73M	0.07%	443
2021 Q1	–	Sell	-3,700	Closed	-$211K	–	1337
2020 Q4	$211K	Buy	+3,700	New	+$219K	0.02%	1064

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

AlphaCrest Capital Management's DCPH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 10,933 shares — an estimated $202K sold.

AlphaCrest Capital Management first reported a position in DCPH in Q4 2020 and held it in 3 quarters. The position peaked at $1.63M in Q2 2021. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

AlphaCrest Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 10,933 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $202K.
AlphaCrest Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
AlphaCrest Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.63M in Q2 2021.
143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.